PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.28%
Negative revenue growth while BIDU stands at 1.35%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
5.17%
Positive gross profit growth while BIDU is negative. John Neff would see a clear operational edge over the competitor.
25.26%
Positive EBIT growth while BIDU is negative. John Neff might see a substantial edge in operational management.
25.26%
Positive operating income growth while BIDU is negative. John Neff might view this as a competitive edge in operations.
32.63%
Positive net income growth while BIDU is negative. John Neff might see a big relative performance advantage.
29.41%
Positive EPS growth while BIDU is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
37.50%
Positive diluted EPS growth while BIDU is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.48%
Share count expansion well above BIDU's 0.05%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.50%
Diluted share count expanding well above BIDU's 0.01%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
16.61%
Positive OCF growth while BIDU is negative. John Neff would see this as a clear operational advantage vs. the competitor.
16.51%
Positive FCF growth while BIDU is negative. John Neff would see a strong competitive edge in net cash generation.
4936.71%
10Y revenue/share CAGR under 50% of BIDU's 20174.98%. Michael Burry would suspect a lasting competitive disadvantage.
158.36%
5Y revenue/share CAGR under 50% of BIDU's 960.94%. Michael Burry would suspect a significant competitive gap or product weakness.
90.72%
3Y revenue/share CAGR under 50% of BIDU's 54961.85%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
160.21%
OCF/share CAGR of 160.21% while BIDU is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
64.64%
3Y OCF/share CAGR of 64.64% while BIDU is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
4495.38%
Below 50% of BIDU's 40874.16%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
125.74%
Below 50% of BIDU's 1116.42%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
40.81%
Below 50% of BIDU's 30351.09%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
198.26%
Below 50% of BIDU's 1136.56%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
91.85%
Below 50% of BIDU's 441.65%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
9.94%
AR growth is negative/stable vs. BIDU's 38.88%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-18.28%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
4.53%
Asset growth well under 50% of BIDU's 39.69%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
4.91%
Under 50% of BIDU's 12.30%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-10.78%
We’re deleveraging while BIDU stands at 398.29%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-12.49%
Our R&D shrinks while BIDU invests at 14.16%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-1.96%
We cut SG&A while BIDU invests at 23.27%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.